On June 22/23/24 we have presented a three days EUFOREA-EPOS webinar: “EPOS 2020: Everything you need to know” Chaired by Professor Wytske Fokkens and Professor Valerie Lund. We are happy to share with our members and readers the video presentations and slides for open use.Please follow this link to access the webinars and the slides to […]
EPOS2020 will be the latest in the EPOS series of guidelines on rhinosinusitis from an international cohort of experts in the field and will build on the success of the previous EPOS papers.
The core objective of the EPOS2020 guideline is to provide real, practical, collaborative management strategies for rhinosinusitis based on a combination of evidence based and clinically relevant research. The aim is to build on the success of previous EPOS position papers, in particular EPOS2012, which was widely acclaimed for its presentation of science translated into clinical care and treatment of disease. EPOS2012 can also be credited with the sharp rise in understanding of separate endotypes in CRS and the relationship to different phenotypes. This knowledge will lead to significant adjustments in the management of CRS, especially in CRSwNP.